Profile data is unavailable for this security.
About the company
Scorpius Holdings, Inc., formerly NightHawk Biosciences, Inc., is an integrated contract development and manufacturing company. The Company is focused on advancing biologic and cell therapy programs to the clinic and beyond. It offers a broad array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its facilities in San Antonio, Texas. Its analytical services include development of a comprehensive range of analytical test methods to characterize complex biologics, including cell therapy-based products, protein therapeutics, vaccines and advanced therapies. Its Clinical Biomanufacturing includes cGMP Mammalian Cell Culture, and cGMP Microbial Fermentation. Its San Antonio facility is focused on the commercial-scale manufacturing of biodefense-focused molecules and biologics therapeutics. Its biomanufacturing services focus on accelerating product development timelines from pre-clinical evaluation to first-in-human studies.
- Revenue in USD (TTM)2.23m
- Net income in USD-46.05m
- Incorporated2008
- Employees77.00
- LocationScorpius Holdings Inc627 DAVIS DRIVE, SUITE 300MORRISVILLE 27560United StatesUSA
- Phone+1 (919) 240-7133
- Fax+1 (302) 636-5454
- Websitehttps://www.nighthawkbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Titan Pharmaceuticals Inc | 185.00k | -5.57m | 6.29m | 4.00 | -- | 0.8096 | -- | 34.00 | -7.40 | -7.40 | 0.246 | 8.50 | 0.0305 | -- | 4.51 | 46,250.00 | -91.72 | -96.80 | -138.02 | -156.65 | -- | -- | -3,010.27 | -406.26 | 5.55 | -- | 0.07 | -- | -66.97 | -51.16 | 45.43 | -- | -65.61 | -- |
| CeCors Inc | -100.00bn | -100.00bn | 6.31m | 6.00 | -- | -- | -- | -- | -- | -- | -- | -0.0163 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 22.70 | -- | -- | -- |
| Lixte Biotechnology Holdings Inc | 0.00 | -5.09m | 6.50m | 3.00 | -- | 13.14 | -- | -- | -2.77 | -2.77 | 0.00 | 1.78 | 0.00 | -- | -- | 0.00 | -103.09 | -104.18 | -111.07 | -111.05 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 19.41 | -- | -- | -- |
| Azitra Inc | 686.00k | -12.64m | 6.52m | 10.00 | -- | 0.9402 | -- | 9.51 | -2.99 | -2.99 | 0.0713 | 0.2408 | 0.1117 | -- | 4.88 | 68,600.00 | -183.73 | -- | -266.83 | -- | -- | -- | -1,644.87 | -- | -- | -45.86 | 0.0138 | -- | 141.55 | -- | 6.02 | -- | -- | -- |
| Xenetic Biosciences Inc | 2.54m | -4.13m | 6.58m | 4.00 | -- | 0.6717 | -- | 2.59 | -2.70 | -2.70 | 1.66 | 6.36 | 0.2006 | -- | -- | 634,995.00 | -32.65 | -48.91 | -35.27 | -52.82 | -- | -- | -162.78 | -682.42 | -- | -- | 0.00 | -- | 48.80 | -- | 36.90 | -- | -- | -- |
| Palisade Bio Inc | 250.00k | -12.30m | 6.59m | 9.00 | -- | 0.423 | -- | 26.36 | -28.22 | -28.22 | 0.5485 | 18.30 | 0.0168 | -- | 0.3153 | 27,777.78 | -82.51 | -132.36 | -101.58 | -165.45 | -- | -- | -4,920.00 | -27,892.32 | -- | -856.33 | 0.0138 | -- | -- | -0.7814 | 13.74 | -- | 18.53 | -- |
| Glucose Health Inc | 1.11m | -456.46k | 6.65m | 2.00 | -- | 7.02 | -- | 5.98 | -0.033 | -0.033 | 0.0803 | 0.0561 | -- | -- | -- | -- | -- | -86.94 | -- | -153.95 | 47.19 | 40.68 | -31.99 | -56.93 | 313.11 | -- | 0.00 | -- | 98.39 | 24.94 | 16.87 | -- | -- | -- |
| Kineta Inc | 5.44m | -14.10m | 6.70m | 11.00 | -- | 2.12 | -- | 1.23 | -1.43 | -1.43 | 0.5297 | 0.278 | 0.3927 | -- | -- | 494,727.30 | -101.57 | -66.16 | -318.39 | -86.61 | -- | -- | -258.65 | -854.74 | -- | -1,310.25 | 0.2011 | -- | 178.65 | 13.89 | 77.76 | -- | -- | -- |
| Scorpius Holdings Inc | 2.23m | -46.05m | 6.70m | 77.00 | -- | 0.1336 | -- | 3.01 | -1.78 | -2.00 | 0.0859 | 1.39 | 0.0234 | -- | 0.6762 | 28,918.57 | -50.05 | -38.42 | -61.25 | -42.06 | 29.10 | -- | -2,136.28 | -703.02 | -- | -- | 0.2305 | -- | 202.12 | 33.24 | -23.85 | -- | 218.50 | -- |
| Cannabis Bioscience Internatnl Hlgs Inc | 56.94m | 6.94m | 6.75m | 389.00 | 0.0012 | 0.0001 | 0.7315 | 0.1185 | 0.5328 | 0.5328 | 4.29 | 4.92 | 0.5917 | 62.81 | 1.45 | 146,384.30 | 7.83 | -- | 11.73 | -- | 31.96 | -- | 13.24 | -- | 0.6856 | 50.75 | 0.0631 | -- | 12.79 | -- | 177.84 | -- | -- | -- |
| Adial Pharmaceuticals Inc | 0.00 | -7.00m | 6.89m | 4.00 | -- | 0.6925 | -- | -- | -5.83 | -4.17 | 0.00 | 2.45 | 0.00 | -- | -- | 0.00 | -133.76 | -182.35 | -174.49 | -235.45 | -- | -- | -- | -- | -- | -55.50 | 0.00 | -- | -- | -- | 35.14 | -- | -- | -- |
| Theriva Biologics Inc | 0.00 | -18.35m | 6.91m | 21.00 | -- | 0.187 | -- | -- | -1.15 | -1.15 | 0.00 | 2.31 | 0.00 | -- | -- | 0.00 | -28.88 | -36.95 | -32.40 | -40.16 | -- | -- | -- | -- | -- | -- | 0.0056 | -- | -- | -- | 8.37 | -- | 95.91 | -- |
| AiXin Life International Inc | 4.09m | -2.09m | 7.00m | 207.00 | -- | -- | -- | 1.71 | -0.0836 | -0.0836 | 0.1636 | -0.0765 | 0.8268 | 5.43 | 10.02 | 19,757.49 | -42.27 | -16.93 | -- | -34.54 | 16.25 | 48.13 | -51.12 | -36.96 | 0.1515 | -- | -- | -- | 51.00 | 58.08 | 67.18 | -- | 194.59 | -- |
| Calidi Biotherapeutics Inc | 0.00 | -28.74m | 7.04m | 38.00 | -- | -- | -- | -- | -0.6324 | -0.6324 | 0.00 | -0.0241 | 0.00 | -- | -- | 0.00 | -284.51 | -- | -- | -- | -- | -- | -- | -- | -- | -25.25 | 1.25 | -- | -89.98 | -- | -132.57 | -- | -- | -- |
Data as of May 04 2024. Currency figures normalised to Scorpius Holdings Inc's reporting currency: US Dollar USD
4.42%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2023 | 465.64k | 1.29% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 396.71k | 1.10% |
| Geode Capital Management LLCas of 31 Dec 2023 | 211.48k | 0.59% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 108.07k | 0.30% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 102.98k | 0.29% |
| Bridgeway Capital Management LLCas of 31 Dec 2023 | 100.00k | 0.28% |
| BG Fund Management Luxembourg SAas of 30 Jun 2023 | 71.63k | 0.20% |
| HRT Financial LLCas of 31 Dec 2023 | 54.91k | 0.15% |
| Northern Trust Investments, Inc.(Investment Management)as of 31 Dec 2023 | 46.82k | 0.13% |
| Two Sigma Securities LLCas of 31 Dec 2023 | 32.86k | 0.09% |
More ▼
Data from 31 Dec 2023 - 29 Feb 2024Source: FactSet Research Systems Inc.
